insights_auto
Why is BOT up 5,56%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,019 A$
arrow_upward
+5,56%(+0,0010) 1D
1 հոկ, 16:10:19 GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
47,22 մլն
Avg. vol.
5,84 մլն
Volume
15,48 մլն
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
47,22 մլն
Avg. vol.
5,84 մլն
Volume
15,48 մլն
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
News stories
From web sources and news partners
PR Web
·
17 րոպե առաջ
Youth INC to Honor Nasdaq's Bob McCooey with the John C. Whitehead Leadership Award
巴士的報
·
12 րոպե առաջ
Kroger Launches Mastercard Powered by Payments Platform Imprint: NYSE Content Update
CNBC
·
2 ժամ առաջ
The Dow's rough month, Micron's revenue surge, Google launches Gemini 4 and more in Morning Squawk
Yahoo Finance
·
26 րոպե առաջ
Had You Bought This Vanguard ETF at the Start of January, You'd be Obliterating the S&P 500 in 2026
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd